Lowe was one of the first people to blog from inside the pharmaceutical industry, with the approval of his supervisor and the company legal department,[5] and one of the first science bloggers.[6] By 2006, his blog had between 3,000 and 4,000 visitors per day during the workweek; he covered business matters, trends and issues in medicinal chemistry, and legal matters like patent law and regulation.[7] At that time he was working at a pharmaceutical company doing
hit to lead medical chemistry work.[7] As of 2010[update] his blog received between 15,000 and 20,000 page views on a typical weekday.[8] His response to a 2013 article in
BuzzFeed that propagated
chemophobia was widely cited.[9][10][11]
Lowe, Derek B. (2016). The Chemistry Book: From Gunpowder to Graphene, 250 Milestones in the History of Chemistry. Sterling.
ISBN9781454911807.
Selected scientific papers
Greenlee, W; Clader, J; et al. (April 2001). "Muscarinic agonists and antagonists in the treatment of Alzheimer's disease". Farmaco. 56 (4): 247–50.
doi:
10.1016/s0014-827x(01)01102-8.
PMID11421251.
Lowe, DB; Magnuson, S; et al. (21 June 2004). "In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase". Bioorganic & Medicinal Chemistry Letters. 14 (12): 3155–9.
doi:
10.1016/j.bmcl.2004.04.015.
PMID15149665.
Rudolph, J; Esler, WP; et al. (18 October 2007). "Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity". Journal of Medicinal Chemistry. 50 (21): 5202–16.
doi:
10.1021/jm070071+.
PMID17887659.
"Interview: Derek Lowe". The Sceptical Chymist: A Nature Chemistry blog. 18 May 2007. Archived from
the original on 4 July 2008. Retrieved 1 August 2010.